Furosemide vs Spironolactone

For acute decompensated heart failure, furosemide is the first-line diuretic for rapid fluid removal ^[1][4]. Its potent diuretic effect can relieve pulmonary edema and peripheral edema within hours. IV furosemide is a standard emergency treatment.

Spironolactone's role in heart failure is different — it provides mortality benefit. The RALES trial demonstrated that spironolactone 25 mg daily reduced mortality by 30% in severe heart failure (NYHA III-IV) when added to standard therapy ^[3]. This survival benefit goes beyond its mild diuretic effect and relates to its aldosterone-blocking properties that prevent cardiac fibrosis.

For resistant hypertension, spironolactone has emerged as an effective add-on therapy based on the PATHWAY-2 trial ^[2]. Furosemide is not typically used for hypertension management except in patients with significant renal impairment.

For cirrhotic ascites, both are used: spironolactone is the first-line diuretic, often combined with furosemide in a 100:40 mg ratio for optimal sodium excretion with potassium balance ^[1][2].

Furosemide's main risks relate to its potent diuresis: hypokalemia, hyponatremia, dehydration, hypotension, and ototoxicity (especially with IV dosing) ^[1]. Electrolyte monitoring is essential. Other effects include hyperuricemia (gout risk), hyperglycemia, and metabolic alkalosis ^[1].

Spironolactone's primary risk is hyperkalemia, especially in patients with renal impairment or those taking ACE inhibitors/ARBs ^[2]. Unique to spironolactone are its anti-androgenic effects: gynecomastia (breast enlargement in men, 10%), breast tenderness, and menstrual irregularities ^[2]. These effects limit tolerability in some male patients and have led to the development of eplerenone, a more selective aldosterone antagonist without anti-androgenic effects.

Both medications can cause dizziness and hypotension. Renal function and electrolytes should be monitored regularly with either medication ^[1][2].

Both are available as inexpensive generics. Furosemide costs $4-$10 per month ^[5]. Spironolactone costs $10-$25 per month ^[5]. Both are covered by all insurance plans.

Furosemide is available in oral tablets (20-80 mg), oral solution, and IV injection for emergency use ^[1]. It is typically dosed 1-2 times daily, with doses timed for practical diuresis (morning to avoid nighttime urination). Spironolactone is available as oral tablets (25-100 mg) and is taken once or twice daily ^[2]. Furosemide's IV availability makes it essential for acute settings; spironolactone is oral-only.

These medications serve different clinical purposes and are often used together rather than as alternatives ^[1][2].

Furosemide is the right choice for rapid fluid removal in acute heart failure, edema from liver/kidney disease, and situations requiring potent diuresis ^[1]. Spironolactone is the right choice for mortality reduction in heart failure, resistant hypertension, cirrhotic ascites, and as a potassium-sparing complement to loop diuretics ^[2][3].

In many heart failure patients, both are prescribed simultaneously — furosemide for fluid management and spironolactone for its survival benefit and potassium-balancing effect ^[3][4].

This information is for educational purposes only. Diuretic therapy requires medical supervision with regular electrolyte and kidney function monitoring.